Addressing Insulin Denial in Pakistan: A Growing Concern in Diabetes Management

Diabetes is a growing public health crisis in Pakistan, with over 33 million adults affected as of 2021. Among the various treatment options, insulin therapy is crucial for managing type 1 diabetes (T1D) and advanced type 2 diabetes (T2D). However, a significant issue known as "insulin denial" has emerged, where patients resist or refuse insulin therapy despite medical indications. This phenomenon is driven by psychological factors, such as fear and stigma; socio-cultural beliefs that associate insulin with severe complications; and healthcare-related challenges, including inadequate access and support. The consequences of insulin denial can be severe, leading to uncontrolled diabetes and life-threatening complications, which also place an economic burden on individuals and the healthcare system. To address this issue, a multi-faceted approach is essential, including public awareness campaigns, improved healthcare provider training, better access to insulin, and psychosocial support for patients. By tackling insulin denial, Pakistan can enhance diabetes management and improve patient outcomes.